Catalyst Wire Dossier Catalyst Wire Dossier

PRO-118

PRO-118 · Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-118, covering 2018-10-02 to 2018-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis [Phase 3]

See pricing